Verition Fund Management
AMPH icon

Verition Fund Management’s Amphastar Pharmaceuticals AMPH Stock Holding History

Verition Fund Management’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-18,597
Closed -$364K – 2080
2026
Q1 		$364K Buy
+18,597
New +$455K ﹤0.01% 1703
2025
Q1 		– Sell
-6,338
Closed -$235K – 3306
2024
Q4 		$235K Buy
6,338
+1,176
+23% +$53.8K ﹤0.01% 2902
2024
Q3 		$251K Sell
5,162
-1,349
-21% -$59.2K ﹤0.01% 2747
2024
Q2 		$260K Buy
+6,511
New +$270K ﹤0.01% 2435
2023
Q4 		– Sell
-8,597
Closed -$395K – 2311
2023
Q3 		$395K Buy
8,597
+3,052
+55% +$166K ﹤0.01% 1573
2023
Q2 		$319K Buy
+5,545
New +$246K ﹤0.01% 1520
2017
Q1 		– Sell
-12,299
Closed -$227K – 1152
2016
Q4 		$227K Buy
+12,299
New +$239K 0.02% 980

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Verition Fund Management's AMPH Position: Q2 2026 in Review

Verition Fund Management sold out of Amphastar Pharmaceuticals (AMPH) in Q2 2026, closing a stake of 18,597 shares — an estimated $364K sold.

Verition Fund Management first reported a position in AMPH in Q4 2016 and held it in 7 quarters. The position peaked at $395K in Q3 2023. 211 funds tracked by Wall St. Rank hold AMPH as of Q2 2026.

  • Verition Fund Management reported no remaining Amphastar Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Verition Fund Management sold 18,597 Amphastar Pharmaceuticals shares in Q2 2026, an estimated $364K.
  • Verition Fund Management first reported a position in Amphastar Pharmaceuticals in Q4 2016 and held it in 7 quarters.
  • Verition Fund Management's Amphastar Pharmaceuticals position peaked at $395K in Q3 2023.
  • 211 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2026.

Based on Verition Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.